AgentRx AI Pharmacist Agents — Enterprise Trust and Safety Layer

Document Information

Field| Value
Document| TRUST_AND_SAFETY_LAYER.md
System| AgentRx AI Pharmacist Agents
Classification| Enterprise Trust and Safety Architecture Specification
Version| 1.0
Owner| AgentRx Trust, Safety, and Architecture Team
Status| Production-Ready Draft
Last Updated| 2026-06-02

---

1. Purpose

This document defines the enterprise Trust and Safety Layer for the AgentRx AI Pharmacist Agents platform.

The Trust and Safety Layer is responsible for preventing unsafe automation, enforcing agent boundaries, protecting patients, preserving licensed human authority, detecting high-risk workflows, ensuring auditability, minimizing PHI exposure, and routing uncertain cases to the correct human review process.

AgentRx is a pharmacy workflow support system. It must not operate as an autonomous pharmacist, prescriber, legal authority, fraud investigator, or dispensing system.

---

2. Trust and Safety Mission

The mission of the Trust and Safety Layer is to ensure that every AgentRx workflow remains safe, explainable, reviewable, auditable, and human-supervised.

The layer must protect against:

- Unsafe prescription automation
- Hallucinated or fabricated prescription data
- Missed medication safety issues
- Human review bypass
- Controlled-substance automation risk
- PHI exposure
- Unauthorized access
- Tool misuse
- Prompt injection
- OCR or extraction overconfidence
- Hidden workflow failures
- Untraceable decisions
- Unsafe downstream handoffs

The system must always prefer human review over unsafe automation.

---

3. Core Trust and Safety Principles

Every trust and safety control must follow these principles:

1. Patient safety first — safety takes priority over speed, automation, throughput, and convenience.
2. Human authority preserved — licensed pharmacy staff remain the final decision-makers.
3. No unsupported autonomy — agents must not approve, dispense, diagnose, prescribe, substitute, or determine legal validity.
4. Conservative uncertainty handling — missing, ambiguous, or low-confidence data must trigger review.
5. Source evidence preservation — every safety-critical field should be traceable to source evidence.
6. No fabrication — agents must never invent missing prescription, patient, prescriber, or medication data.
7. Fail-safe execution — unsafe failures must block automation and route to review.
8. PHI minimization — sensitive health information must only be used where necessary.
9. Auditability — safety-relevant decisions must be traceable and reviewable.
10. Defense against manipulation — untrusted inputs must not override system rules or safety controls.

---

4. Layer Responsibilities

The Trust and Safety Layer is responsible for:

- Enforcing safety invariants across agents, tools, APIs, workflows, and review queues.
- Detecting unsafe or incomplete prescription data.
- Blocking automation when risk exists.
- Requiring human review for safety-critical uncertainty.
- Validating agent outputs against approved schemas.
- Detecting hallucination, fabrication, or unsupported inference.
- Preserving source evidence and confidence metadata.
- Preventing controlled-substance workflows from bypassing review.
- Protecting PHI from unnecessary exposure.
- Detecting prompt injection and malicious document content.
- Enforcing tool permission boundaries.
- Requiring audit events for safety-relevant actions.
- Routing failed workflows to safe recovery queues.

The layer is not responsible for final clinical verification, dispensing approval, legal determination, fraud accusation, or patient counseling.

---

5. High-Level Trust and Safety Architecture

flowchart TD
    A[Input Channels] --> B[Input Risk Screening]
    B --> C[Document and OCR Safety Checks]
    C --> D[Agent Runtime Safety Gates]
    D --> E[Schema and Output Validation]
    E --> F[Workflow Safety Gate Engine]
    F --> G{Automation Safe?}
    G -->|No| H[Human Review Layer]
    G -->|Yes| I[Standard Review / Next Workflow]
    H --> J[Licensed Human Decision]
    D --> K[Audit and Evidence Store]
    E --> K
    F --> K
    H --> K
    K --> L[Governance and Monitoring]

---

6. Trust and Safety Control Points

Control Point| Purpose
Input Screening| Detect unsupported files, malicious content, and non-prescription submissions
OCR Safety Check| Identify low-confidence, unreadable, cropped, or distorted prescription evidence
Extraction Safety Check| Detect missing, ambiguous, or conflicting extracted prescription fields
Agent Boundary Check| Ensure agents remain within their approved responsibilities
Schema Validation| Reject malformed, incomplete, or unsafe outputs
Safety Flag Evaluation| Identify issues that block automation
Human Review Gate| Route unsafe, uncertain, or high-risk cases to authorized humans
Tool Permission Check| Prevent unapproved tool use or data access
PHI Exposure Check| Minimize sensitive data in logs, prompts, telemetry, and outputs
Audit Integrity Check| Ensure safety-relevant events are captured and traceable

---

7. Safety-Critical Domains

The Trust and Safety Layer must apply stricter controls to the following domains:

Domain| Safety Concern
Patient Identity| Wrong-patient risk, demographic mismatch, duplicate profiles
Prescriber Identity| Missing signature, invalid contact data, unclear credentials
Medication Identity| Wrong-drug risk, look-alike/sound-alike risk, OCR ambiguity
Medication Strength| Wrong-dose risk, handwritten ambiguity, unit confusion
SIG / Directions| Incomplete or conflicting directions
Quantity and Refills| Alteration risk, mismatch with SIG, controlled-substance concern
Controlled Substances| Regulatory and patient safety risk requiring enhanced review
Source Document Quality| Poor scan, blur, crop, missing page, unreadable handwriting
Workflow Integrity| Unsafe state transition, skipped validation, bypassed review
PHI Handling| Unauthorized disclosure or excessive data exposure

---

8. Core Safety Invariants

The following invariants must always hold across AgentRx:

if (safetyFlags.some(flag => flag.blocksAutomation)) {
  decision.automationAllowed = false;
}

if (errors.length > 0) {
  decision.requiresHumanReview = true;
  decision.automationAllowed = false;
}

if (controlledSubstanceSuspected === true) {
  decision.requiresHumanReview = true;
  decision.automationAllowed = false;
}

if (auditLoggingFailed === true) {
  decision.requiresHumanReview = true;
  decision.automationAllowed = false;
}

if (schemaValidationFailed === true) {
  decision.requiresHumanReview = true;
  decision.automationAllowed = false;
}

if (medicationSafetyCriticalUncertainty === true) {
  decision.requiresHumanReview = true;
  decision.automationAllowed = false;
}

No agent, tool, API, workflow, or reviewer interface may silently override these invariants.

---

9. Human Review Gate Rules

Human review is mandatory when:

- Medication name is missing, ambiguous, or low-confidence.
- Medication strength is missing, ambiguous, conflicting, or low-confidence.
- SIG or directions are missing, incomplete, or unclear.
- Quantity or refills are missing, altered, conflicting, or low-confidence.
- Patient identity is missing, ambiguous, or conflicts with profile data.
- Prescriber identity, signature, or credential information is missing or conflicting.
- Controlled-substance indicators are detected.
- Possible tampering or alteration indicators are detected.
- Source document quality prevents safe extraction or verification.
- Agent output violates schema.
- Safety-critical tools fail.
- Audit logging fails.
- PHI redaction fails.
- Workflow state is inconsistent.
- Any agent operates outside its approved scope.

Required decision pattern:

{
  "requiresHumanReview": true,
  "automationAllowed": false,
  "severity": "high",
  "reviewReasons": [
    "Safety-critical uncertainty detected"
  ]
}

---

10. Enterprise Standard

The AgentRx Trust and Safety Layer exists to ensure that pharmacy automation remains safe, bounded, transparent, and human-supervised.

Its success is not measured by how much automation it allows.

Its success is measured by how reliably it prevents unsafe, uncertain, unsupported, or non-compliant automation from advancing without the right licensed human review.